<DOC>
	<DOCNO>NCT01780649</DOCNO>
	<brief_summary>Intracytoplasmic Morphologically Selected Sperm ( IMSI ) modification IntraCytoplasmic Sperm Injection ( ICSI ) choice spermatozoon inject do 6000x magnification instead 400x commonly use ICSI . The purpose study evaluate efficiency indication IMSI multicentric randomise trial .</brief_summary>
	<brief_title>Evaluation IMSI Treat Male Infertility</brief_title>
	<detailed_description>Intracytoplasmic sperm injection ( ICSI ) largely use treat male infertility . Usually , choice spermatozoon inject do 400x magnification . Recently , new microscopic technic ( Intracytoplasmic Morphologically Selected Sperm Injection-IMSI ) allow make choice 6000x magnification , permit identify sperm abnormality nuclear vacuole see conventional ICSI . This selection may improve ICSI outcome . However data randomise trial , publish indication IMSI remain identified . The present study aim evaluate efficiency indication IMSI multicentric randomise trial . The patient enrol study must present male infertility complete sperm examination , include morphology , DNA fragmentation nuclear immaturity . The main endpoint percentage delivery .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility , Male</mesh_term>
	<criteria>male infertility le 1 million motile spermatozoon recover gradient preparation least 3 million sperm cell ejaculate First Assisted reproductive technology ( ART ) attempt Female age &gt; 38 Female follicle stimulate hormone ( FSH ) level &gt; 9</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>IMSI</keyword>
	<keyword>ICSI</keyword>
	<keyword>ART Assisted reproductive technology</keyword>
	<keyword>Spermatozoa</keyword>
	<keyword>male infertility</keyword>
	<keyword>vacuole</keyword>
</DOC>